Dr. Steve Finkbeiner and his team at the Gladstone Institutes have developed an AI-powered “thinking microscope” that can independently run experiments, learn from what it observes, and rapidly analyze data — far beyond human capacity. By applying AI approaches similar to large language models, the system can “learn the language of biology” to uncover patterns and predict outcomes, while reducing human bias.
The platform is already being applied to stem cell–based models of Alzheimer’s, Parkinson’s, and ALS, with the potential to dramatically accelerate discovery of new treatments. Rather than replacing scientists, it automates routine tasks, freeing researchers to focus on higher-level insights and interpretation. Watch his recent interview below.